Guidelines for the management of adult lower respiratory tract infections ‐ Full version

Clin Microbiol Infect 2011; 17(Suppl. 6): E1–E59 Abstract This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010. It provides evidence‐based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI. Topics include management outside hospital, management inside hospital (including community‐acquired pneumonia (CAP), acute exacerbations of COPD (AECOPD), acute exacerbations of bronchiectasis) and prevention. Background sections and graded evidence tables are also included. The target audience for the Guideline is thus all those whose routine practice includes the management of adult LRTI.

• Publication year

  2011

• Venue

  Clinical Microbiology and Infection

• Publication date

  2011-09-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1469-0691.2011.03672.xPMID 21951385PMCID 7128977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease.

  2015cited by this paper
• Prophylactic antibiotic therapy for chronic bronchitis.

  2013cited by this paper
• Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings.

  2012cited by this paper
• Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.

  2012cited by this paper
• Acute Respiratory Failure in Patients with Severe Community-acquired Pneumonia

  2012cited by this paper
• Early Switch to Oral Treatment in Patients with Moderate to Severe Community-Acquired Pneumonia

  2012cited by this paper
• WITHDRAWN: Antibiotics for exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Beta2-agonists for acute bronchitis.

  2011cited by this paper
• Respiratory Syncytial Virus Infection in Adults

  2011influential reference
• Antibiotics for exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

  2010cited by this paper
• Influenza vaccination for healthcare workers who work with the elderly.

  2010cited by this paper
• Vaccines for preventing influenza in the elderly.

  2010cited by this paper
• Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

  2010cited by this paper
• Q fever in the Netherlands: an update on the epidemiology and control measures.

  2010cited by this paper
• Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia.

  2010cited by this paper
• Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods

  2010influential reference
• Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

  2010cited by this paper
• Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.

  2010cited by this paper
• Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

  2010cited by this paper
• [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].

  2010cited by this paper
• Quantitative real-time PCR tests for diagnostic and prognostic purposes in cases of legionellosis.

  2010cited by this paper
• Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia

  2009cited by this paper
• Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.

  2009influential reference
• Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

  2009influential reference
• C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.

  2009cited by this paper
• Statin use and risk of community acquired pneumonia in older people: population based case-control study

  2009cited by this paper
• Respiratory Syncytial Virus Outbreak in a Long‐Term Care Facility Detected Using Reverse Transcriptase Polymerase Chain Reaction: An Argument for Real‐Time Detection Methods

  2009cited by this paper
• Relation of sputum colour to bacterial load in acute exacerbations of COPD.

  2009cited by this paper
• Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

  2009influential reference
• Diagnosis of Streptococcus pneumoniae Infections in Adults with Bacteremia and Community-Acquired Pneumonia: Clinical Comparison of Pneumococcal PCR and Urinary Antigen Detection

  2009cited by this paper
• Procalcitonin and severity of community-acquired pneumonia

  2009influential reference
• Non‐invasive ventilation in do‐not‐intubate patients: five‐year follow‐up on a two‐year prospective, consecutive cohort study

  2009influential reference
• Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

  2009cited by this paper
• Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.

  2009influential reference
• Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in Catalonia, Spain, 1990-2004.

  2009cited by this paper
• Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling.

  2009influential reference
• Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia.

  2009cited by this paper
• Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

  2009cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2009influential reference
• Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?

  2009cited by this paper
• Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations

  2009cited by this paper
• Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

  2009cited by this paper
• Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region.

  2009cited by this paper
• Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review.

  2009cited by this paper
• Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.

  2009cited by this paper
• Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

  2009cited by this paper
• Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study

  2009cited by this paper
• Comparison of the sensitivity of the Legionella urinary antigen EIA kits from Binax and Biotest with urine from patients with infections caused by less common serogroups and subgroups of Legionella

  2009cited by this paper
• Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.

  2009influential reference
• Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak

  2009cited by this paper
• The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review.

  2009cited by this paper
• Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

  2009cited by this paper
• New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

  2009cited by this paper
• Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain

  2009cited by this paper
• Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks.

  2009cited by this paper
• Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

  2009cited by this paper
• Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ)

  2009cited by this paper
• Statins for the prevention and treatment of infections: a systematic review and meta-analysis.

  2009cited by this paper
• Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia.

  2009cited by this paper
• Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia.

  2009cited by this paper
• C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.

  2009cited by this paper
• Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia*

  2009cited by this paper
• Streptococcus pneumoniae DNA Load in Blood as a Marker of Infection in Patients with Community-Acquired Pneumonia

  2009cited by this paper
• Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.

  2009cited by this paper
• Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

  2009influential reference
• Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.

  2009cited by this paper
• Near‐patient assays for diagnosis of influenza virus infection in adult patients

  2009cited by this paper
• Severity of pneumococcal pneumonia associated with genomic bacterial load.

  2009cited by this paper
• Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold

  2009cited by this paper
• The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine.

  2009cited by this paper
• Role of ‘atypical pathogens’ among adult hospitalized patients with community‐acquired pneumonia

  2009cited by this paper
• Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia*

  2009cited by this paper
• Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors

  2009cited by this paper
• Aetiology of, and risk factors for, recurrent community-acquired pneumonia.

  2009cited by this paper
• A prospective study of the diagnostic utility of sputum Gram stain in pneumonia.

  2009cited by this paper
• Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia

  2009cited by this paper
• Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.

  2009cited by this paper
• Detection of Haemophilus influenzae in respiratory secretions from pneumonia patients by quantitative real-time polymerase chain reaction.

  2009cited by this paper
• Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital.

  2009cited by this paper
• Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

  2009cited by this paper
• Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin

  2009cited by this paper
• The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test

  2009influential reference
• Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD

  2009cited by this paper
• Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

  2009cited by this paper
• Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia

  2009cited by this paper
• Severe respiratory disease concurrent with the circulation of H1N1 influenza.

  2009cited by this paper
• Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.

  2009cited by this paper
• Evaluation of the Oxoid Xpect Legionella Test Kit for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine

  2009cited by this paper
• Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

  2009cited by this paper
• Comparative efficacy of inactivated and live attenuated influenza vaccines.

  2009cited by this paper
• Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

  2008cited by this paper
• Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

  2008cited by this paper
• New evidence of risk factors for community-acquired pneumonia: a population-based study

  2008cited by this paper
• Antimicrobial Susceptibilities of 930 Haemophilus influenzae Clinical Strains Isolated from the Island of Crete, Greece

  2008cited by this paper
• Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila

  2008cited by this paper
• Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?

  2008cited by this paper
• A Systematic Review of the Preventive Effect of Oral Hygiene on Pneumonia and Respiratory Tract Infection in Elderly People in Hospitals and Nursing Homes: Effect Estimates and Methodological Quality of Randomized Controlled Trials

  2008cited by this paper
• Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

  2008cited by this paper
• Modification of the Risk of Mortality from Pneumonia with Oral Hygiene Care

  2008cited by this paper

• Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System

  2026cites this paper
• Antibiotic use for respiratory tract infections in nursing homes: a multicentre cross-sectional study

  2026cites this paper
• Bacterial meningitis in adults: therapeutic challenges in the era of antibiotic resistance and the potential of bacteriophages and associated by products.

  2026cites this paper
• An overview of respiratory tract infections in South Africa

  2026cites this paper
• Epidemiological shifts in pediatric respiratory pathogens in Shenzhen, China: impacts of COVID-19 control measures and relaxation

  2026influential citation
• The Role of Complex Digital Interventions to Improve Pneumonia Care

  2026cites this paper
• Antibiotic duration for common bacterial infections—a systematic review

  2025cites this paper
• Detecting Respiratory Pathogens for Diagnosing Lower Respiratory Tract Infections at the Point of Care: Challenges and Opportunities

  2025cites this paper
• The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia

  2025cites this paper
• Clinical features and survival analysis of adult patients with severe lower respiratory tract infection positive for respiratory syncytial virus

  2025cites this paper
• Hyperbilirubinemia at hospitalization predicts nosocomial infection in decompensated cirrhosis: Data from ATTIRE trial

  2025cites this paper
• A new pathogen pattern of acute respiratory tract infections in primary care after COVID-19 pandemic: a multi-center study in southern China

  2025cites this paper
• Poor Prognosis of Pneumococcal Co-Infection in Hospitalized Patients with COVID-19: A Propensity Score-Matched Analysis

  2025cites this paper
• Clinical characteristics and predictive models for hospitalized patients with COVID-19 combined with bacterial pneumonia

  2025cites this paper
• Can neutrophil/lymphocyte ratio, C-reactive protein (CRP) and procalcitonin predict the hospitalization time in patients with lower tract respiratory infections?

  2025cites this paper
• Antibiotic combination indications for the treatment of community-acquired acute pneumonia.

  2025cites this paper
• An antibiotic stewardship initiative focused on community-acquired bacterial pneumonia (CABP) in outpatient clinics and urgent care centers: a 2023–2024 community health system experience

  2025cites this paper
• The prospects and challenge of pathogen diagnosis of lower respiratory tract infections in grassroots hospitals: The clinical practicality of targeted nextgeneration sequencing

  2025cites this paper
• Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction.

  2025cites this paper
• Diagnostic and prognostic potential of plasma and sputum thrombomodulin in bacterial community-acquired pneumonia

  2025cites this paper
• A Review on the Role of Moxifloxacin in the Treatment and Management of Respiratory Tract Infections

  2025cites this paper
• Efficacy and safety of a new drug formulation, amoxicillin-clavulanate-cineole, for adult lower respiratory tract infections: a nationwide observational study in Morocco

  2025cites this paper
• A Nanoparticle-Based Immunoassay on Facemasks for Evaluating Neutrophilic Airway Inflammation in COPD Patients

  2025cites this paper
• Comprehensive management of pneumonia in older patients.

  2025cites this paper
• Respiratory Syncytial Virus and COVID‐19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use

  2025cites this paper
• Circulating levels of adiponectin and AdipoR expression in peripheral blood mononuclear cells are associated with lower respiratory tract Infection

  2025cites this paper
• Clinical features, pathogens, and prognosis of immunocompromised host pneumonia in patients with malignancies

  2025cites this paper
• C-reactive protein point-of-care testing to guide antibiotic prescribing for respiratory tract infections

  2025cites this paper
• Deaths from Acute Respiratory Infections are Linked to High Fasting Blood Glucose and Decreased Levels of Low-Density Lipoprotein/Small Dense Low-Density Lipoprotein

  2025cites this paper
• mRNA–miRNA integration analysis of T‐cell exhaustion in sepsis from community‐acquired pneumonia

  2025cites this paper
• ОСОБЛИВОСТІ ПОКАЗНИКІВ ЛІПІДОГРАМИ У ХВОРИХ З COVID-19 АСОЦІЙОВАНОЮ ПНЕВМОНІЄЮ ТА ОБЛІТЕРУЮЧИМ АТЕРОСКЛЕРОЗОМ СУДИН НИЖНІХ КІНЦІВОК

  2025cites this paper
• Personnes âgées et kinésithérapie respiratoire, est-ce vraiment utile ?

  2025cites this paper
• Efficacy of a deep learning-based software for chest X-ray analysis in an emergency department.

  2025cites this paper
• The impact of a multifaceted intervention on antibiotic use for common infections in nursing homes in Spain. A before and after study

  2025cites this paper
• Diagnostic superiority of serial increase in C-reactive protein versus single measurement in differentiating bacterial from non-bacterial etiologies in pediatric patients.

  2025cites this paper
• The diagnostic value of RNA-mNGS and DNA-mNGS in differentiating bacterial infection from colonization in the lower respiratory tract

  2025cites this paper
• Beyond Pneumonia: A Dual-Cycle Initiative to Improve Imaging Compliance and Uncover Early Malignancy

  2025cites this paper
• Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial

  2025cites this paper
• Clinical features and prognosis of severe legionnaires’ disease requiring intensive care unit admission: a multicentric retrospective cohort study

  2025cites this paper
• Antibiotic susceptibility according to age of clinical strains from hospital respiratory samples: A nationwide study.

  2025cites this paper
• Epidemiology, resistance profiles, and risk factors of multidrug- and carbapenem-resistant Serratia marcescens infections: a retrospective study of 242 cases

  2025cites this paper
• Can we rely on using penicillin as the first-line treatment of pneumonia in outpatient care?

  2025cites this paper
• Predominance of gram-negative multidrug-resistant pathogens causing lower respiratory tract infections among gene X-pert negative presumptive tuberculosis patients in Dar Es Salaam, Tanzania

  2025cites this paper
• Test and treat—impact of microbiological testing on antibiotic prescribing for Legionnaires’ disease in Switzerland: results of the multicentre SwissLEGIO study

  2025influential citation
• Early re-examination of chest CT may be unnecessary when patients with psittaci pneumonia at low and intermediate risk on Pneumonia Severity Index present with response to initial treatment

  2025cites this paper
• Acute bronchitis: updated clinical guidelines. A review

  2025cites this paper
• Effects of C-reactive protein rapid testing and communication skills training on antibiotic prescribing for acute cough. A cluster factorial randomised controlled trial

  2024cites this paper
• Tailored Multifaceted Strategy for Implementing Fundamental Evidence-Based Nursing Care: An Evaluation Study

  2024cites this paper
• Incidence and characteristics of aspiration pneumonia in the Nagasaki Prefecture from 2005 to 2019

  2024cites this paper
• Lung Ultrasonography Accuracy for Diagnosis of Adult Pneumonia: Systematic Review and Meta-Analysis

  2024cites this paper
• Diagnostic value of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in patients with lower respiratory tract infections.

  2024cites this paper
• Risk factors analysis and prediction model construction for severe pneumonia in older adult patients

  2024cites this paper
• Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome

  2024cites this paper
• A rapid and reliable method for early Legionella pneumophila identification and characterization in support of the epidemiology study

  2024cites this paper
• ОСОБЛИВОСТІ ПОКАЗНИКІВ ЗАГАЛЬНОГО АНАЛІЗУ КРОВІ ПРИ КОМОРБІДНОМУ ПЕРЕБІЗІ НЕГОСПІТАЛЬНОЇ ПНЕВМОНІЇ, АСОЦІЙОВАНОЇ З COVID-19, ТА АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇ

  2024cites this paper
• Prevalence of respiratory pathogens among hospitalised patients with acute respiratory infection during and after the COVID-19 pandemic in Shijiazhuang, China

  2024cites this paper
• Antimicrobial Resistance Genes in Legionella from Artificial Water Systems: Findings from a Two-Year Study

  2024cites this paper
• Relation Between Chest Radiography Results and Antibiotic Initiation in Community-Acquired Pneumonia Management by General Practitioners

  2024cites this paper
• A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients

  2024cites this paper
• How can traditional Chinese medicine enhance the efficacy of antibiotics in the treatment of MRSA-infected pneumonia: an experimental study on the combination of Reyanning mixture and linezolid.

  2024cites this paper
• Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY

  2024cites this paper
• Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care

  2024cites this paper
• C-reactive protein point-of-care testing in primary care—broader implementation needed to combat antimicrobial resistance

  2024cites this paper
• Guidelines for Antibiotics Prescription in Critically Ill Patients

  2024cites this paper
• Comment on: Community-acquired pneumonia: a US perspective on the guideline gap

  2024cites this paper
• Effects of early treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on the bronchoalveolar lavage proteome and oxylipids during bovine respiratory syncytial virus (BRSV) infection

  2024cites this paper
• Lung ultrasound and procalcitonin, improving antibiotic management and avoiding radiation exposure in pediatric critical patients with bacterial pneumonia: a randomized clinical trial

  2024cites this paper
• Evaluating the Sputum Bacteriological Profile of Lower Respiratory Tract Infections With Bartlett Score Analysis in a Tertiary Care Hospital in Southern Karnataka

  2024cites this paper
• Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study

  2024cites this paper
• Prevalence and predictors of antibiotic prescription among patients hospitalized with viral lower respiratory tract infections in Southern Province, Sri Lanka

  2024cites this paper
• Diagnostic value of DNA or RNA-based metagenomic next-generation sequencing in lower respiratory tract infections

  2024cites this paper
• Causes, outcomes and diagnosis of acute breathlessness hospital admissions in Malawi: protocol for a multicentre prospective cohort study

  2024cites this paper
• [Short antibiotic therapy in hospitalized pneumonia: A cohort study].

  2024cites this paper
• Accordance of Registered Drug Packages with Guideline-Recommended Treatment Durations for Community-Acquired Pneumonia—A New Antibiotic Stewardship Target?

  2024cites this paper
• Guideline-Concordant Therapy for Community-Acquired Pneumonia in the Hospitalized Population: A Systematic Review and Meta-analysis

  2024cites this paper
• Antimicrobial Resistance of Streptococcus pneumoniae Clinical Serotypes between 2017 and 2022 in Crete, Greece

  2024cites this paper
• Bacterial etiology of community-acquired pneumonia among adult patients in Ethiopia: A systematic review and meta-analysis

  2024cites this paper
• Validating the accuracy of deep learning for the diagnosis of pneumonia on chest x-ray against a robust multimodal reference diagnosis: a post hoc analysis of two prospective studies

  2024cites this paper
• Development of a predictive machine learning model for pathogen profiles in patients with secondary immunodeficiency

  2024cites this paper
• Identification and Clinical Characteristics of Community-Acquired Acinetobacter baumannii in Patients Hospitalized for Moderate or Severe COVID-19 in Peru

  2024cites this paper
• The Role of Targeted Next-Generation Sequencing in Pathogen Detection

  2024cites this paper
• Сontemporary approaches to the treatment of acute bronchitis: benefits of herbal medicine

  2024cites this paper
• Syndromic testing for respiratory pathogens but not National Early Warning Score can be used to identify viral cause in hospitalised adults with lower respiratory tract infections

  2024cites this paper
• PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial

  2024cites this paper
• Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective

  2024cites this paper
• Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial

  2024cites this paper
• A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients

  2024cites this paper
• Comparative analysis of clinical features of lower respiratory tract infection with respiratory syncytial virus and influenza virus in adults: a retrospective study

  2023cites this paper
• Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study

  2023cites this paper
• Antimicrobial Stewardship in Immunocompromised Patients: Current State and Future Opportunities.

  2023cites this paper
• Aetiology of Community-Acquired Pneumonia and the Role of Genetic Host Factors in Hospitalized Patients in Cyprus

  2023cites this paper
• Immunisation against respiratory diseases

  2023cites this paper
• Bacterial etiology, antimicrobial resistance and factors associated with community acquired pneumonia among adult hospitalized patients in Southwest Ethiopia

  2023cites this paper
• Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial etiology.

  2023cites this paper
• Impact of serial cardiopulmonary point-of-care ultrasound exams in patients with acute dyspnoea: a randomised, controlled trial

  2023cites this paper
• Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study.

  2023cites this paper
• Practical aspects of the application of a new drug combination of ambroxol+guaiphenesine+ levosalbutamol in the treatment of acute bronchitis in adults. Experts council resolution

  2023cites this paper
• Antibiotic Treatment for Lower Respiratory Tract Infections in Primary Care: A Register-Based Study Examining the Role of Radiographic Imaging

  2023cites this paper
• Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data

  2023cites this paper
• Magnetic Levitation System Isolates and Purifies Airborne Viruses.

  2023cites this paper